Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats

Neuropharmacology. 2012 Jun;62(8):2515-21. doi: 10.1016/j.neuropharm.2012.01.031. Epub 2012 Feb 8.

Abstract

Background and objective: Evidence shows that acetylcholinergic transmission in the ventral tegmental area (VTA) or nucleus accumbens (NAc) plays an important role in heroin-seeking induced by cues. Cholinergic modulation of VTA neurons arises from the lateral dorsal tegmental nucleus (LDT). The present studies investigated the effect of systemic or intra- LDT administration of galantamine, an inhibitor of acetylcholinesterase, on heroin-seeking induced by cues.

Methods: Rats were trained to self-administer heroin for 12 days, underwent extinction training for 12 days followed by two weeks in their home cages. Then the conditioned cues were introduced for the reinstatement of heroin-seeking.

Results: The reinstatement of heroin-seeking induced by cues was attenuated by the administration of galantamine (0, 0.3, 1 or 3mg/kg, i.p.) in a dose-dependent manner. In contrast, galantamine only at the dose of 3mg/kg could inhibit the reinstatement of sucrose-seeking. Galantamine at those doses failed to alter the locomotor activity in heroin-withdrawn rats. The inhibition of drug-seeking by galantamine was reversed by pretreatment with scopolamine (0.5mg/kg) but not with mecamylamine (3mg/kg) or scopolamine methobromide (1mg/kg). Moreover, the microinjection of galantamine into the LDT blocked cue-induced heroin-seeking, while the microinjection of scopolamine into the LDT reversed the inhibitory effect of galantamine on drug-seeking behavior.

Conclusion: The results suggest that cholinergic transmission in the LDT may play a critical role in heroin-seeking behavior induced by cues and that galantamine may have the beneficial effect of blocking heroin-seeking behavior, which is mediated through its actions on the muscarinic receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Cholinergic Antagonists / pharmacology
  • Cholinesterase Inhibitors / pharmacology*
  • Cues
  • Drug-Seeking Behavior / drug effects*
  • Extinction, Psychological / drug effects
  • Galantamine / pharmacology*
  • Heroin / administration & dosage
  • Heroin / adverse effects*
  • Mecamylamine / pharmacology
  • Motor Activity / drug effects
  • Narcotics / administration & dosage
  • Narcotics / adverse effects
  • Nucleus Accumbens / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Scopolamine / pharmacology
  • Self Administration
  • Substance Withdrawal Syndrome / drug therapy*
  • Ventral Tegmental Area / drug effects

Substances

  • Cholinergic Antagonists
  • Cholinesterase Inhibitors
  • Narcotics
  • Galantamine
  • Mecamylamine
  • Heroin
  • Scopolamine